Home
Esportazione
Statistica
Opzioni
Visualizza tutti i metadati (visione tecnica)
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter
Bravaccini, Sara
•
Ravaioli, Sara
•
Tumedei, Maria Maddalena
altro
Maltoni, Roberta
2020
journal article
Periodico
CLINICAL CANCER RESEARCH
Abstract
N/A
DOI
10.1158/1078-0432.CCR-20-0668
WOS
WOS:000551370100043
Archivio
https://hdl.handle.net/11368/3040178
info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85088155470
https://aacrjournals.org/clincancerres/issue/26/14
Diritti
open access
license:copyright editore
license:digital rights management non definito
license uri:iris.pri02
license uri:iris.pri00
FVG url
https://arts.units.it/request-item?handle=11368/3040178
Soggetti
atezolizumab
nab-paclitaxel
triple-negative breas...
programmed death liga...
google-scholar
Vedi dettagli